Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese

Paty Karoll Picardi1, Vivian Cristine Calegari, Patricia Oliveira Prada

  • 1Departamento de Clínica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.

Endocrinology
|May 10, 2008
PubMed

Insights

Reducing hypothalamic PTP1B (Protein tyrosine phosphatase 1B) improved insulin and leptin sensitivity, leading to reduced food intake and body weight. This suggests PTP1B inhibition as a therapeutic target for obesity and metabolic disorders.

Area of Science:

  • Metabolism
  • Neuroendocrinology
  • Molecular Biology

Background:

  • Protein tyrosine phosphatase 1B (PTP1B) negatively regulates insulin and leptin signaling pathways.
  • PTP1B knockout mice exhibit enhanced insulin/leptin sensitivity and resistance to diet-induced obesity.
  • The specific role of hypothalamic PTP1B in metabolic regulation requires further elucidation.

Purpose of the Study:

  • To investigate the function of hypothalamic PTP1B in regulating food intake, body weight, and insulin/leptin signaling in rats.
  • To determine if selective reduction of PTP1B in the hypothalamus impacts metabolic parameters in control and obese rats.

Main Methods:

  • Selective, transient reduction of PTP1B expression in hypothalamic nuclei using antisense oligonucleotides.
  • Administration of antisense oligonucleotides via infusion into hypothalamic areas surrounding the third ventricle in control and obese rats.
  • Assessment of food intake, body weight, adiposity, and insulin/leptin signaling pathways.

Main Results:

  • Selective decrease in hypothalamic PTP1B led to reduced food intake and body weight.
  • Hypothalamic PTP1B reduction decreased adiposity following high-fat feeding.
  • Improved insulin and leptin action and signaling in the hypothalamus was observed.
  • Potential role in improving glucose metabolism in obese rats with diabetes.

Conclusions:

  • Targeting hypothalamic PTP1B offers a promising strategy for managing obesity and related metabolic dysfunctions.
  • Selective PTP1B inhibition in the hypothalamus enhances insulin and leptin sensitivity.
  • Further research into PTP1B's role in glucose homeostasis is warranted.

Related Concept Videos

Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...